Method for therapeutically treating psoriatic arthritis using vi

Details Method for therapeutically treating psoriatic arthritis using vi Method for therapeutically treating psoriatic arthritis using vi

1990-12-14

1992-03-24

Pal, Asok

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

9,10-seco- cyclopentanohydrophenanthrene ring system doai

514168, 514 35, 514863, A01N 4500, A61K 3159

Patent

active

050988999

ABSTRACT:
A novel and effective treatment of psoriatic arthritis is provided using biologically active forms of vitamin D analogues and metabolites, and preferrably 1,25-dihydroxy vitamin D.sub.3. The administration of vitamin D analogues and metabolites may be made orally, topically, or parenterally. Substitive improvements in both the arthritic condition and skin lesions result after approximately two month's treatment when effective dosages are provided and maintained.

REFERENCES:
patent: 3903071 (1975-09-01), Holmes
patent: 4325965 (1982-04-01), Chiba
patent: 4326055 (1982-04-01), Loeliger
patent: 4410515 (1983-10-01), Holick et al.
patent: 4521410 (1985-06-01), Holick et al.
patent: 4610978 (1986-09-01), Dikstein et al.
patent: 4728643 (1988-03-01), Holick et al.
patent: 4804651 (1989-02-01), Duvic et al.
Robert N. Bennet, "Psoriatic Arthritis", in Arthritis and Allied Conditions: A Textbook of Rheumatology, (by Daniel J. McCarthy), 11th edition, Lea & Febiger, 1989, Chapter 61, pp. 954-971.

Affiliated with

Also associated with

Rating

Method for therapeutically treating psoriatic arthritis using vi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for therapeutically treating psoriatic arthritis using vi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for therapeutically treating psoriatic arthritis using vi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2010331